Objectives: Diabetes mellitus has been one of the most crippling diseases that man has seen, and its prevalence has risen dramatically over the past two decades. Currently, there are over 150 million diabetics worldwide and this number is likely to increase to 300 million or more by the year 2025. Diabetes mellitus increases the risk of many disorders including cardiovascular diseases. Understanding the molecular properties of diabetic progression is a big challenge in the system biology era. The aim of this study is to determine association in albumin modifications between Chernobyl clean-up workers with and without type 2 diabetes mellitus. Methods: ABM (3-aminobenzanthrone derivative developed in Daugavpils University, Latvia) has been previously shown as a potential biomarker for determination of the immune state of patients with different pathologies. In this study several aspects of plasma albumin alterations in the group of Chernobyl clean-up workers with diabetes mellitus in relation to the group of workers without diabetes mellitus and people having no professional contact with radioactivity were determined. The following parameters were examined: (1) spectral characteristics of ABM in blood plasma; (2) effective and total albumin concentration in blood plasma; and (3) quantitative parameters of albumin auto-fluorescence. Results: Screening of individuals with diabetes mellitus 25-26 years after their work in Chernobyl revealed two groups of patients differing in structural and functional properties of blood plasma albumin. The revealed structural modifications of albumin are dependent on radiation-induced factors. Concomitant diseases (diabetes mellitus, cardiovascular diseases) reinforce radiationinduced effects. Conclusion: ABM is a sensitive probe of albumin alterations; it can be used to elucidate the changes in protein systems. Significant differences in albumin dynamics exist between the control group (donors) and that of diabetics and non-diabetics in the Chernobyl clean-up workers.
INTRODUCTION
Disturbances in structural and functional properties of albumin play an important role in the pathogenesis of various diseases, including atherosclerosis and diabetes mellitus [1, 2] . Diabetes mellitus has been one of the most crippling diseases that man has seen, and its prevalence has risen dramatically over the past two decades. Currently, there are over 150 million diabetics worldwide and this number is likely to increase to 300 million or more by the year 2025 [3] . Diabetes mellitus increases the risk of many disorders including cardiovascular diseases. Understanding the molecular properties of diabetic progression is a big challenge in the system biology era. Blood plasma proteins are an ideal window for observing global and dynamic progression of pathologies since the circulation system is the basic "highway" of the body for transporting all kinds of metabolism related molecules [4] .
Albumin is most generously represented in the human blood plasma. Therefore it is important to study and evaluate the transportation function of albumin in clinical examinations [4] . Many issues regarding structure and properties of plasma albumin remain unclear, among them physical properties of albumin are related to this structure, functional role of ligands, and transportation of oxidation products; the latter in various pathologies. Quality analysis of changes in albumin properties can help in determination of mutual conformities and peculiarities of changes in all the above mentioned parameters in the organism with various pathologies (e.g. patients with cardiovascular diseases, etc) and/or under the influence of external factors (ionizing radiation).
Spectral characteristics of probes (benzanthrone derivatives) satisfy all requirements for ideal tracers. It has been shown previously that the probe ABM exhibits high affinity for model and biological membranes [5] [6] [7] . The lymphocyte membrane and albumin of Chernobyl clean-up workers was examined using ABM probe in 1996-1997 and re-examined in 2006-2007 on the same individuals [5, 8, 9] . The changes in cell membrane system of Chernobyl cleanup workers with type 2 diabetes mellitus are described in our previous article [10] . Screening revealed two groups of patients differing in structural and functional membrane properties, first of all the lipid/protein interrelations and conformations of membrane proteins. The obtained structural modifications of membrane are dependent on radiation-induced factors. Concomitant diseases reinforce radiation-induced effects on membrane.
The aim of this study was to determine several aspects of plasma albumin alterations in the same patients (individuals) of Chernobyl clean-up workers with type 2 diabetes mellitus in relation to the group of workers without diabetes mellitus and humans having no professional contact with radioactivity. The main goal of the present study was to investigate the evolution of albumin alterations in patients with type 2 diabetes mellitus and estimation of its connection with vascular complications.
MATERIALS AND METHODS

Study subjects
The study subjects were randomly selected from Latvia's residents who had participated in the clean-up work in Chernobyl. In 2011, 25 years after the accident, 3 groups of Chernobyl clean-up workers (including patients with type 2 diabetes mellitus) were selected. All Chernobyl clean-up workers had different concomitant diseases. Individuals who had been under treatment for acute infection, active autoimmune diseases and malignant tumours were excluded. The control group (n = 17, male) consisted of healthy individuals of corresponding age who never had professional contact with radioactivity.
ABM
ABM (conventional name) was synthesized in Daugavpils University, Daugavpils, Latvia [6] . Synthesis of ABM, its properties and results of the research carried out to determine the immune state of patients with different pathologies was summarised previously [5] .
Blood collection
The Ethics Committee of the Medical Academy of Latvia approved the protocol of the present study design. Peripheral blood samples for plasma albumin studies were drawn usually at 8-10 a.m.; the venous blood was collected in vacutainer tubes containing heparin 30 IU per tube.
Effective and total albumin content in blood plasma
Effective albumin (EA) concentration is a signal of "healthy" albumin in blood plasma, measured by the fluorescent method (in this case using probe ABM). Fluorescence intensity is in proportion to the number of free unoccupied binding sites of plasma albumin (equivalent of "healthy" albumin in blood plasma) [4] . The total albumin (TA) concentration was measured by using bromcresol purple [11] . The content of total albumin in the samples was calculated by the calibration curve of the dependence of fluorescense intensity on the concentration of albumin in the blood plasma sample of healthy donors. Reserve of albumin binding capacity was determined as EA/TA.
Albumin auto-fluorescence
In the investigations of albumin auto-fluorescence, fluorescence spectra were measured at the excitation wavelength 286 nm. The fluorescence of human plasma albumin is dominated by tryptophanyl (330 nm) [4, 12] .
Sample preparation and fluorescence measurements
Like in earlier studies, the present investigations were performed using the ABM fluorescent probe [9] [10] [11] [12] 13] developed in Daugavpils University. In the current study, blood plasma (200-fold diluted) incubated without probe was used in each experiment as each patient's personal 'blank'. ABM (resulting concentration in sample = 19.6 µmol/l) was added to 1 ml aliquot of each patient's blood plasma at the temperature of 18-20ºC, and the mixture was then allowed to set for about 5 min. The time interval between plasma isolation and fluorescence measurement was held constant for all samples (i.e. 3 hr). Resulting fluorescence parameters were then registered by the Spectrofluo JY3 spectrofluorimeter (ISA Jobin Yvon Instruments S.A., Longjumeau, France) at the excitation wavelength of 470 nm and an emission wavelength of 520-700 nm. To register luminescence, every sample was placed in a cuvette (1 x 10 x 40 mm 3 ) fixed at the angle of 30° to the excitation light beam. Fluorescence intensity was then recorded and reported in terms of arbitrary units (AU). The final intensity value for each patient's sample was then calculated taking into account a corresponding personal 'blank'; this approach thereby eliminated any potential contributions from any auto-fluorescing constituents in the plasma sample.
Statistical analysis
Statistical differences among groups having different spectral characteristics were determined using the Student's t-test and Mann-Whitney U test. Correlative relationships between spectral charasteristics of the ABM and the measured lymphocyte parameters were determined as outlined by Duncan [14] . The correlations were determined according to Pearson Correlation Coefficients (PCC) using the following PCC values: r = 0.1-0.4, weak; r = 0.4-0.7, midstrength; and r > 0.7, strong.
RESULTS
Our investigations included the study of the structural state of blood plasma albumin by using the fluorescent methods. The spectral characteristics of ABM in blood plasma, plasma auto-fluorescence, and binding with plasma albumin were examined. 
Characteristics of observed groups of patients
ABM spectral characteristics in plasma
The emission maximum of ABM in lymphocyte suspension for healthy donors is 650 nm; fluorescence intensity F = 0.68 AU. Screening groups of the cleanup workers in 25-26 years after their work in Chernobyl showed the following patterns of fluorescence spectra (see Table 1 ). 
Albumin auto-fluorescence
There is strong correlation between ABM fluorescence intensity in blood plasma and level of tryptophanyl region dehydration of albumin molecule [15] . The shifts of fluorescence zone to the short-wave region and decreased fluorescence intensity in Chernobyl clean-up workers provide evidence of hydration of tryptophanyl region of the albumin molecule [4, 12] . Results testify to a more significant hydration process in the albumin tryptophanyl region in diabetics (groups 1 and 2) as compared with group 3 and the control group. These data explained a lower intensity of ABM fluorescence in blood plasma for groups 1 and 2, as compared to group 3 and the control group.
ABM binding with plasma albumin
Effective albumin concentration in patients of groups 1, 2 and 3 decreased by 51.8%, 44% and 26.8%, respectively. The lowest value of EA/TA in plasma of these patients reached 0.45 (group 1), 0.53 (group 2), and 0.66 (group 3); in the donor group, it is 0.79-0.81 (Table 1) .
DISCUSSION
Diabetes mellitus is a sample of metabolic disorder not only in the membrane structure, but also in blood albumin. Many questions regarding structure and properties of albumin remain unclear, among them physical properties related to albumin structure (especially in molecule tryptophan area), functional role of ligand and transportation of oxidation products during various pathologies. The reason for examining albumin is that this protein is practically the only source of ABM binding in blood plasma with a very high selectivity and subsequent fluorescence [5, 13, 15] .
Probe ABM was approbated on patients with gastrointestinal cancer [13, 15] and humans exposed to ionizing radiation during the clean-up work in Chernobyl [8, 9] . In groups of Chernobyl clean-up workers, the patterns in spectral characteristics of ABM resemble the so-called N-F transition of albumin with the blue shift of fluorescence maximum to 602-620 nm and increased fluorescence intensity as compared to the healthy control group. In groups of patients having no contact with radioactivity, the wave length of ABM emissions and fluorescence intensity was not changed in comparison with the value decrease in the control group. The balance of pathological and pharmacological metabolites (fatty acids, antioxidants, plasma levels of lipid peroxidation products, etc) levels differs in groups of patients unlike the controls, and hence their correlation with seizure pathophysiology [8, 9] . Our previous biochemical investigations provide evidence that these workers have a sustained oxidant stress injury. Changes in blood plasma and its structural and functional properties detected by probe ABM strongly correlated with oxidant/antioxidant (immune) status of individuals [8, 9] .
According to the obtained data, the levels of oxidative protein damage in plasma showed significant changes in diabetic patients compared with the control group. Obtained shifts in binding parameters is in agreement with the observations of Rolinsky et al [12] who noted that albumin molecules contained different binding sites (i.e. classes) that differed in affinity, quantum yield, and degrees of polarization, i.e. higher mobility of a bound probe and increased accessibility by water, for ABM and various other probes.
The fluorescent method reveals the effective concentration of albumin (equivalent to 'healthy' albumin in blood plasma). The total concentration of albumin is conservative [4, 5] . The present study reveals significant changes in ABM fluorescence associated with plasma albumin of the patients in the observed groups. The shift of the probe fluorescence maximum to the short-wave region may also be an evidence of hydration of the tryphtophanyl region in an albumin molecule [4] . Rigidity (dehydration) of the trypthophanyl region is more expressed in group 1 as compared to the control group and group 2. The fluorescence intensity of ABM in it is by 50% more significant than that in the control group and group 2. Tryptophanyl residue is located in the conformationally labile hydrophobic fold of the structure which is accessible for water. The hydrophobic fold is closed due to albumin transformation, and the environment of trypthophanyl becomes more rigid as a result of this process (dehydrated) [4, 5] . The additional "binding shifts" seen in plasma samples of diabetes mellitus patients could be partly due to decreased binding of albumin caused by conformational changes in it. These shifts can provide basis for the development of various diabetic complications.
The obtained results clarify the heterogenous nature of albumin molecules and reveal quantitative difference in its conformation in the observed groups of patients. It is intersting to note that all investigated parameters (ABM fluorescence intensity, effective albumin concentration, dehydration of tryptophanyl region of molecule, etc) were more pronounced in groups of diabetic patients (groups 1 and 2) than in the non-diabetic group of Chernobyl clean-up workers and control group. The higher levels of modified albumin could be related to the severity of disease.
On the whole, an albumin molecule in diabetics is modified in the chronic hypoxia conditions provoked mainly by the hyperglycemia and oxidative stress. The concomitant diseases reinforce the radiation-induced effect on albumin. The ABM probe as a biomarker of modified albumin could also help to identify individuals with complex metabolic conditions who have a higher risk of suffering from cardiovascular diseases.
